These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2754556)

  • 21. Elevated serum immunoreactive pancreatic cationic trypsinogen in acute malnutrition: evidence of pancreatic damage.
    Durie PR; Forstner GG; Gaskin KJ; Weizman Z; Kopelman HR; Ellis L; Largman C
    J Pediatr; 1985 Feb; 106(2):233-8. PubMed ID: 3968610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis.
    Gaskin KJ; Durie PR; Corey M; Wei P; Forstner GG
    Pediatr Res; 1982 Jul; 16(7):554-7. PubMed ID: 7110775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pancreas physiopathology in cystic fibrosis].
    Kashirskaia NIu; Kapranov NI; Kusova ZA; Shelepneva NE
    Eksp Klin Gastroenterol; 2010; (8):98-103. PubMed ID: 21268333
    [No Abstract]   [Full Text] [Related]  

  • 24. [Release of pancreatic polypeptide after administration of cholecystokinin in children with mucoviscidosis].
    Cichy W; Socha J; Barra E
    Pediatr Pol; 1985 Jun; 60(6):440-4. PubMed ID: 4069838
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of the function of the sweat gland, parotid gland and the pancreas in chronic bronchitis and heterozygous mucoviscidosis or cystic fibrosis.
    Toivonen S
    Ann Med Intern Fenn; 1967; 56(50):Suppl 50:9-48. PubMed ID: 6050826
    [No Abstract]   [Full Text] [Related]  

  • 26. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).
    Kerem E; Corey M; Kerem BS; Rommens J; Markiewicz D; Levison H; Tsui LC; Durie P
    N Engl J Med; 1990 Nov; 323(22):1517-22. PubMed ID: 2233932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis.
    Weber AM; Roy CC; Chartrand L; Lepage G; Dufour OL; Morin CL; Lasalle R
    Gut; 1976 Apr; 17(4):295-9. PubMed ID: 773791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound echo-intensity predicts severe pancreatic affection in cystic fibrosis patients.
    Engjom T; Erchinger F; Lærum BN; Tjora E; Gilja OH; Dimcevski G
    PLoS One; 2015; 10(3):e0121121. PubMed ID: 25803445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the pancreatic and respiratory functions in cystic fibrosis. The influence of the time of the evolution of the disease].
    Ericson N; Navarro S; Valderrama R; Adrián MJ; Lloberes P; Cobos N
    Med Clin (Barc); 1993 Nov; 101(17):650-2. PubMed ID: 8289509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D.
    Parad RB
    J Med Genet; 1996 Aug; 33(8):711-3. PubMed ID: 8863168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of exocrine pancreatic insufficiency in mucoviscidosis].
    Shmerling DH
    Z Allgemeinmed; 1972 Aug; 48(24):1080-4. PubMed ID: 4649650
    [No Abstract]   [Full Text] [Related]  

  • 33. [Exocrine pancreatic function in infants with cystic fibrosis].
    Hager-Malecka B; Janiec W; Lukas W; Kalaciński W; Bielecka W
    Pol Tyg Lek; 1977 Mar; 32(13):485-7. PubMed ID: 850652
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cystic fibrosis: analysis of 24 cases].
    Kimura HM; Rozov T; Barbieri D; Nakaie CM; Cardieri JM
    Rev Paul Med; 1982; 99(1):13-7. PubMed ID: 7146739
    [No Abstract]   [Full Text] [Related]  

  • 35. The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis.
    Colombo C; Maiavacca R; Ronchi M; Consalvo E; Amoretti M; Giunta A
    J Pediatr Gastroenterol Nutr; 1987; 6(6):926-30. PubMed ID: 3681578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex cystic fibrosis allele R334W-R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient.
    Duarte A; Amaral M; Barreto C; Pacheco P; Lavinha J
    Hum Mutat; 1996; 8(2):134-9. PubMed ID: 8844211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cimetidine in cystic fibrosis.
    Ahuja AS; Mann NM
    Arch Dis Child; 1978 Sep; 53(9):766. PubMed ID: 718252
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiological aspects of pancreatic diseases in childhood. The case of cystic fibrosis.
    Mastella G; Baldessari G; Olivieri D; Pederzini F; Rizzotti P; Zanchetta M; Burlina A
    Ric Clin Lab; 1984; 14(3):367-81. PubMed ID: 6522957
    [No Abstract]   [Full Text] [Related]  

  • 39. Stool elastase as a diagnostic test for pancreatic function in children with cystic fibrosis.
    Wallis C; Leung T; Cubitt D; Reynolds A
    Lancet; 1997 Oct; 350(9083):1001. PubMed ID: 9329517
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.